Chris Florkowski

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Increased Diene Conjugates in Diabetic Subjects with Microangiopathy

Paul Jennings, A.F. Jones, Chris Florkowski et al. · Diabetic Medicine · 1987 · 165 citations

Medicine, Biochemistry, Internal Medicine +11

Effectiveness of EDACS Versus ADAPT Accelerated Diagnostic Pathways for Chest Pain: A Pragmatic Randomized Controlled Trial Embedded Within Practice

Martin Than, John W. Pickering, Sally Aldous et al. · Annals of Emergency Medicine · 2016 · 142 citations · Full text

Medicine, Cardiology, Emergency Medicine +16

HbA1c as a Diagnostic Test for Diabetes Mellitus - Reviewing the Evidence.

Chris Florkowski · PubMed · 2013 · 126 citations

Medicine, Internal Medicine, Clinical Decision Support +16